Group 1 - The fund will suspend accepting large subscriptions exceeding 1 million yuan starting from August 14, 2025, but has decided to resume large subscriptions immediately due to the elimination of previous influencing factors [1] - Investors can check relevant information on the company's website or contact customer service for inquiries [1] Group 2 - From August 20, 2025, Huatai Securities will be added as a sales institution for certain funds managed by the company, allowing investors to handle various fund-related transactions through Huatai Securities [3] - The company has agreed to participate in fee rate discounts for its funds sold through Huatai Securities, with specific discount rates and terms to be published on Huatai Securities' page [4] Group 3 - The minimum amount for regular investment in funds is set at 10 yuan, and investors can apply for this service at Huatai Securities sales outlets [7] - Investors can consult details through Huatai Securities or the company's customer service [7]

Core Viewpoint - Current data indicates that the impact of tariffs on U.S. inflation remains relatively mild, with core CPI in May-June 2025 falling short of expectations, showing a month-on-month increase of only 0.1-0.2% [1] Group 1: Tariff Impact on Inflation - The limited impact of tariffs on inflation is attributed to several factors: significant inventory accumulation by companies, a temporary buffer against rising tariffs, a weighted import tariff rate lower than theoretical values, weak corporate demand, and low service inflation [1] - It is expected that tariffs will moderately increase U.S. core inflation in the third quarter, although there is market disagreement regarding the magnitude and duration of this inflation rise [1] Group 2: Federal Reserve and Interest Rates - The Federal Reserve is likely to restart the interest rate cut cycle in September, despite anticipated inflation recovery in the third quarter having limited constraints on the Fed's rate cuts in 2025 [1] - Short-term inflation recovery is expected to have a limited impact on U.S. Treasury yields, although the implementation of the "Big and Beautiful" Act may still exert pressure on these yields [1] Group 3: Broader Economic Considerations - Attention should be paid to potential buffers created by financial deregulation, expansion of stablecoins, and changes in U.S. Treasury issuance structure, which may influence the economic landscape [1] - The long-term outlook suggests that the U.S. dollar may face depreciation pressure [1]

华泰证券(06886)发布公告，公司2023年面向专业投资者公开发行公司债券(第七期)，简称"23华泰10"， 将于2025年8月25日开始支付自2024年8月24日至2025年8月23日期间的利息。本期债券票面利率(计息年 利率)为2.64%，每手本期债券面值为人民币1000元，派发利息为人民币26.40元(含税)。 ...

Group 1 - The company Huatai Securities (06886) announced the issuance of short-term corporate bonds aimed at professional investors, with a total issuance amount of RMB 3 billion [1] - The bonds, referred to as "24 Huatai S6," will have a coupon rate of 1.67% and will start paying interest from December 24, 2024, until August 23, 2025 [1] - Each bond will have a principal repayment of RMB 1,000, with a distribution rate of RMB 11.118 (including tax) [1]

随着ETF市场持续升温，券商做市业务竞争格局逐渐清晰。Wind数据显示，广发证券与中信证券在沪深 两大交易所的ETF做市领域占据绝对优势。 ETF市场正迎来爆发式增长。天相投顾周度观察数据显示，截至8月15日，全市场ETF总数达1262只， 总规模逼近4.76万亿元，较年中增长10.5%，创历史新高。伴随规模扩张，基金公司积极引入券商提供 流动性服务，券商做市能力成为关键竞争指标。 目前上交所基金市场名单列有21家做市商，为超700只产品提供流动性支持。其中，广发证券与中信证 券均以服务超560只ETF的数量领跑，华泰证券以超450只位列第三。深交所方面，名单中列有10家做市 商服务超500只ETF，广发证券与中信证券同样以超400只的规模位居前二。 | | 深交所做市商做市ETF情况 | | | --- | --- | --- | | 排名 | 深交所做市商名单 | 参与深交所ETF做市数量(只)。 | | | 中信证券 | 420 | | | 广发证券 | 406 | | | 方正证券 | 285 | | | 华泰证券 | 248 | | 00 4 0 0 0 2 W N - | 招商证券 | 245 | ...

华泰证券（601688）(06886)发布公告，该公司2024年面向专业投资者公开发行短期公司债券(第四期) (以下简称"本期债券")，将于2025年8月25日开始支付自2024年12月24日至2025年8月23日期间的利息和 本期债券的本金。 据悉，本期债券简称"24华泰S6"，发行总额人民币30亿元，票面利率为1.67%，每手本期债券兑付本金 为人民币1000元，派发利率为人民币11.118元(含税)。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不對因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 （於中華人民共和國註冊成立之股份有限公司， 中文公司名稱為華泰證券股份有限公司，在香港以HTSC名義開展業務） （股份代號：6886） 「本公司」 指 於中華人民共和國以華泰證券股份有限公司的公司名 稱註冊成立的股份有限公司，於2007年12月7日由前身 華泰證券有限責任公司改制而成，在香港以「HTSC」 名義開展業務，根據公司條例第16部以中文獲准名稱 「華泰六八八六股份有限公司」及英文公司名稱「Huatai Securities Co., Ltd.」註冊為註冊非香港公司，其H股於 2015年6月1日在香港聯合交易所有限公司主板上市（股 票代碼：6886），其A股於2010年2月26日在上海證券交 易所上市（股票代碼：601688），其全球存託憑證於2019 年6月在倫敦證券交易所上市（證券代碼：HTSC），除文 義另有所指外，亦包括其前身 海外監管公告 承本公司董事會命 聯席公司秘書 張輝 本公告乃根 ...

（於中華人民共和國註冊成立之股份有限公司， 中文公司名稱為華泰證券股份有限公司，在香港以HTSC名義開展業務） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不對因本公告全部或任何部分內容而產生或因倚賴 該等內容而引致的任何損失承擔任何責任。 （股份代號：6886） 海外監管公告 本公告乃根據上市規則第13.10B條規則作出。 茲載列本公司在上海證券交易所網站刊登之《華泰證券股份有限公司2024年面向 專業投資者公開發行短期公司債券（第四期）2025年本息兌付及摘牌公告》，僅供 參閱。 釋義 於本公告，除文義另有所指外，下列詞彙具有以下涵義。 「本公司」 指 於中華人民共和國以華泰證券股份有限公司的公司名 稱註冊成立的股份有限公司，於2007年12月7日由前身 華泰證券有限責任公司改制而成，在香港以「HTSC」 名義開展業務，根據公司條例第16部以中文獲准名稱 「華泰六八八六股份有限公司」及英文公司名稱「Huatai Securities Co., Ltd.」註冊為註冊非香港公司，其H股於 2015年6月1日在香港聯合交易所有限公司主 ...

Core Viewpoint - Huatai Securities reports that JD Health's total revenue for the first half of this year reached 35.29 billion yuan, representing a year-on-year increase of 24.5%, exceeding the market consensus growth expectation of 20.2% [1] Group 1: Revenue and Growth - JD Health's revenue growth is attributed to the rapid increase in traffic from JD's main platform, with daily active users (DAU) of the JD app growing by 44.8%, 33.4%, and 46.4% year-on-year from May to July 2025 according to QuestMobile [1] - The company is expected to benefit from increased advertising demand from upstream partners while enhancing its omnichannel medical service capabilities (B2C + O2O) to retain new users [1] Group 2: Profit Forecast and Valuation - Huatai Securities has raised JD Health's non-International Financial Reporting Standards (Non-IFRS) net profit forecasts for 2025 to 2027 by 26.1%, 32.5%, and 38.8%, projecting profits of 5.57 billion, 6.21 billion, and 6.9 billion yuan respectively [1] - The target price for JD Health has been adjusted from 42.1 HKD to 67.1 HKD, with a target Non-IFRS price-to-earnings ratio of 35 times for 2025, maintaining a "buy" rating [1]

Market Performance - The Shanghai Composite Index reached a new high of 3741.29 points, the highest since August 2015, with a closing increase of 1.18% at 3740.5 points [1][2] - The Shenzhen Component Index and the ChiNext Index both surpassed their previous highs from October 2024, with increases of 2.25% and 3.63% respectively [2] Market Capitalization and Trading Volume - The total market capitalization of A-shares exceeded 110 trillion yuan, reaching 113 trillion yuan, marking a historical high [2] - The trading volume in the market surpassed 1 trillion yuan, with a morning trading volume of 17.221 billion yuan, an increase of 4.114 billion yuan compared to the previous trading day [2] Sector Performance - The film and cinema sector saw significant gains, with companies like Baidu and Huace Film & TV hitting the daily limit [4][5] - The internet finance sector also experienced strong performance, with stocks like Longcheng Securities and Zhinanceng rising sharply [6][7] - Technology stocks rebounded across the board, particularly in the computing industry chain, with significant gains in liquid cooling server stocks and AI-related sectors [8][9] Investment Trends - There is a notable trend of funds migrating from deposits to the stock market, driven by declining deposit rates and increasing financial investment awareness among the private sector [10] - Analysts suggest that the "rain and dew evenly distributed" approach in the market indicates that sectors like finance and technology will continue to perform well [11]